| Drugs by Condition |  |
Head and Neck Cancer Medications
Drugs (by generic name) associated with Head and Neck Cancer
The following drugs and medications are in some way related to, or used in the treatment of Head and Neck Cancer.
This service should be used as a supplement to, and NOT a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
Drug Name  ( View by: Brand | Generic )
|
Reviews | Ratings |
|---|---|---|
docetaxel systemic (Pro, More...) class: mitotic inhibitors | 0 Review(s) | Not rated - Be the first |
Head and Neck Cancer Medications in the Pipeline
Advexin (p53 tumor suppressor therapy)
- September 2, 2008
Introgen Receives Notice Advexin U.S. BLA Not Sufficiently Complete to File - June 30, 2008
Introgen Submits Advexin Regulatory Applications in the U.S. and Europe - December 20, 2007
Introgen Plans to Expand Biomarker Database in Phase 3 Trials and File BLA and MAA for Advexin in Advanced Head and Neck Cancer in First Half of 2008
